MedTrace Logo

Prospective Collection of Female Specimens for Testing With Gen-Probe APTIMA (Registered Trademark) Assays

NCT01728103 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 1336

Last updated 2017-08-16

No results posted yet for this study

Summary

The objective of this study is to obtain female first-catch urine, vaginal, cervical and endocervical swabs for testing with multiple APTIMA Assays on the Gen-Probe PANTHER® and TIGRIS® Systems.

Conditions

  • Chlamydia Infections
  • Gonorrhea
  • Trichomonas Infections

Interventions

DEVICE

APTIMA® Trichomonas vaginalis & APTIMA® COMBO 2® Assays

In Vitro Diagnostic Assays

Sponsors & Collaborators

  • Gen-Probe, Incorporated

    lead INDUSTRY

Principal Investigators

  • Renee Wait · Gen-Probe, Incorporated

Eligibility

Min Age
16 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01728103 on ClinicalTrials.gov